Incidencia y factores de riesgo asociados con nefropatía inducida por medios de contraste en procedimientos intervencionistas de cardiología

Fuentes, Sergio; Sanabria, Miguel; Garnica, Paola; Espinosa, Cristian; San Martin, Carlos Rosselli; Osorio, Nelson William.
Repert. med. cir ; 28(3): 171-177, 2019. ilus., tab.
Artigo em Inglês, Espanhol | LILACS, COLNAL | ID: biblio-1095112

Documentos relacionados

  1. Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.
  2. The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary interventions.
  3. Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography.
  4. Nefropatía inducida por constraste en pacientes oncológicos: Un estudio de casos y controles
  5. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.
  6. Pentoxifylline for the prevention of contrast-induced nephropathy: systematic review and meta-analysis of randomised controlled trials.
  7. Remote Ischemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate Renal Impairment Undergoing Percutaneous Coronary Angiography: A Meta-Analysis.
  8. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
  9. The effect of establishing pre-angiography thresholds on contrast utilization.
  10. The role of pentoxifylline in preventing contrast-induced nephropathy in coronary angiography/intervention - systematic review, meta-analysis, and meta-regression of randomized controlled trials.